NVIDIA and the American College of Radiology (ACR) announced a collaboration to enable thousands of radiologists nationwide to create and use artificial intelligence (AI) for diagnostic radiology in their own facilities, using their own data, to meet their own clinical needs.

Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared to myomectomy, according to new research presented at the Society of Interventional Radiology’s (SIR) 2019 Annual Scientific Meeting, March 23-28 in Austin, Texas.  Women who received this minimally invasive treatment also had a slightly lower need for additional treatment than those who underwent surgery.

Healthereum LLC released the beta version of the Healthereum Life Portfolio, or HELIO, a mobile application that allows patients to be rewarded digital tokens for interacting with their healthcare providers. With each action taken — “Promise to Show” for an appointment, complete quality care surveys after the visit, receive task messages from their doctors and view their current diagnoses — digital tokens are given to the patients’ “wallet” to reward them for time spent on their health using blockchain technology.

Visage Imaging will be exhibiting the latest version of the Visage 7 Enterprise Imaging Platform at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 4-7 in Hollywood, Fla.

The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer their artificial intelligence (AI)-powered region of interest (ROI) radiation exposure reduction solution FluoroShield for interventional X-ray imaging on their flat panel detector CS-series product lines.

IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology Center at MedStar Southern Maryland Hospital Center, based on an IBA Dosimetry independent beam scanning solution.

iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast tomosynthesis (DBT), ProFound AI, as well as its PowerLook Density Assessment software, during the 2019 Society of Breast Imaging (SBI) Annual Symposium, April 4-7, in Hollywood, Fla.

Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are expected to drive growth of virtual reality (VR) in the healthcare market over the next several years, according to new research from Reports and Data. The report projects the market will reach a value of $6.91 billion by 2026. Advancements in the field of information technology (IT), including laptop, computer, internet connectivity and mobile applications will also be a significant factor stimulating market demand.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now